Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms
{{output}}
Background: Neuroendocrine neoplasms (NENs) are rare and biologically heterogeneous tumors with limited evidence-based systemic treatment options, particularly in advanced disease stages. Molecular Tumor Boards (MTBs) offer an in... ...
